More than 110 000 individuals across the US are expected to be diagnosed with head and neck cancer (HNC) in 2021.
1 Owing to fear of disease recurrence, functional deficits, and aesthetic changes, up to 40% of these patients may develop depression at some point in their treatment course.
2-4 Ablative surgery is a necessary step in oncologic control but often disturbs nearby structures that are necessary for self-expression and social interaction.
5 Patients subsequently undergoing head and neck reconstruction emphasize altered facial appearance as a key contributor to impaired psychosocial functioning.
6-8